PRMT7
Basic information
Region (hg38): 16:68310951-68360852
Links
Phenotypes
GenCC
Source:
- short stature-brachydactyly-obesity-global developmental delay syndrome (Supportive), mode of inheritance: AR
- short stature-brachydactyly-obesity-global developmental delay syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Short stature, brachydactyly, intellectual developmental disability, and seizures | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed mediCONDITIONScal decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 26437029 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (167 variants)
- Inborn_genetic_diseases (106 variants)
- Short_stature-brachydactyly-obesity-global_developmental_delay_syndrome (56 variants)
- PRMT7-related_disorder (15 variants)
- not_specified (14 variants)
- Self-injurious_behavior (2 variants)
- Obesity (2 variants)
- Hyperlipidemia (2 variants)
- Lumbar_hyperlordosis (2 variants)
- Acanthosis_nigricans (2 variants)
- Hepatic_steatosis (2 variants)
- Abnormality_of_the_dentition (2 variants)
- Insulin_resistance (2 variants)
- Intellectual_disability,_severe (2 variants)
- Short_stature (2 variants)
- Skeletal_dysplasia (2 variants)
- Abnormal_facial_shape (2 variants)
- Short_metacarpal (2 variants)
- Neurodevelopmental_abnormality (2 variants)
- Brachydactyly (2 variants)
- Renal_hypoplasia (2 variants)
- Epileptic_encephalopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRMT7 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000019023.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 55 | 61 | ||||
| missense | 130 | 13 | 155 | |||
| nonsense | 10 | 14 | ||||
| start loss | 0 | |||||
| frameshift | 13 | |||||
| splice donor/acceptor (+/-2bp) | 8 | |||||
| Total | 20 | 25 | 132 | 68 | 6 |
Highest pathogenic variant AF is 0.00012892397
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PRMT7 | protein_coding | protein_coding | ENST00000339507 | 17 | 47590 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 5.50e-15 | 0.536 | 125656 | 0 | 92 | 125748 | 0.000366 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.683 | 386 | 426 | 0.907 | 0.0000261 | 4550 |
| Missense in Polyphen | 80 | 107.92 | 0.74132 | 1117 | ||
| Synonymous | -0.734 | 190 | 178 | 1.07 | 0.0000122 | 1313 |
| Loss of Function | 1.62 | 28 | 38.9 | 0.720 | 0.00000192 | 417 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000568 | 0.000567 |
| Ashkenazi Jewish | 0.000100 | 0.0000992 |
| East Asian | 0.000275 | 0.000272 |
| Finnish | 0.000102 | 0.0000924 |
| European (Non-Finnish) | 0.000503 | 0.000501 |
| Middle Eastern | 0.000275 | 0.000272 |
| South Asian | 0.000301 | 0.000294 |
| Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA), with a preference for the formation of MMA. Specifically mediates the symmetrical dimethylation of arginine residues in the small nuclear ribonucleoproteins Sm D1 (SNRPD1) and Sm D3 (SNRPD3); such methylation being required for the assembly and biogenesis of snRNP core particles. Specifically mediates the symmetric dimethylation of histone H4 'Arg-3' to form H4R3me2s. Plays a role in gene imprinting by being recruited by CTCFL at the H19 imprinted control region (ICR) and methylating histone H4 to form H4R3me2s, possibly leading to recruit DNA methyltransferases at these sites. May also play a role in embryonic stem cell (ESC) pluripotency. Also able to mediate the arginine methylation of histone H2A and myelin basic protein (MBP) in vitro; the relevance of such results is however unclear in vivo. {ECO:0000269|PubMed:15044439, ECO:0000269|PubMed:15494416, ECO:0000269|PubMed:17709427, ECO:0000269|PubMed:19110445}.;
- Disease
- DISEASE: Short stature, brachydactyly, intellectual developmental disability, and seizures (SBIDDS) [MIM:617157]: An autosomal recessive disease characterized by developmental delay, learning disabilities, mild mental retardation, delayed speech, and skeletal abnormalities. Skeletal features include short stature, brachydactyly, and short metacarpals and metatarsals. {ECO:0000269|PubMed:26437029}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization
(Consensus)
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- loftool
- 0.663
- rvis_EVS
- -1.9
- rvis_percentile_EVS
- 1.95
Haploinsufficiency Scores
- pHI
- 0.0472
- hipred
- Y
- hipred_score
- 0.545
- ghis
- 0.587
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.924
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Prmt7
- Phenotype
- neoplasm; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; liver/biliary system phenotype; embryo phenotype; skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- spliceosomal snRNP assembly;regulation of gene expression by genetic imprinting;regulation of transcription, DNA-templated;histone methylation;peptidyl-arginine methylation;peptidyl-arginine methylation, to symmetrical-dimethyl arginine;peptidyl-arginine methylation, to asymmetrical-dimethyl arginine;cell differentiation;histone arginine methylation;DNA methylation involved in gamete generation;regulation of protein binding;histone H4-R3 methylation
- Cellular component
- fibrillar center;nucleus;nucleoplasm;cytosol
- Molecular function
- histone-arginine N-methyltransferase activity;S-adenosylmethionine-dependent methyltransferase activity;protein-arginine N-methyltransferase activity;[myelin basic protein]-arginine N-methyltransferase activity;protein-arginine omega-N monomethyltransferase activity;protein-arginine omega-N asymmetric methyltransferase activity;protein-arginine omega-N symmetric methyltransferase activity;histone binding;ribonucleoprotein complex binding;histone methyltransferase activity (H4-R3 specific)